CD8A and COVID-19: However, n-Sp6 showed a lack of T-cell activation ability (Supplementary Figures 3A–D), and a low proportion of antigen-specific T cells in convalescent COVID-19 patients (Supplementary Figures 3E, F); therefore, it was not considered as the dominant CD8+ T-cell epitope.